Initial efficacy of anti-lymphocyte activation gene-3 (anti-LAG-3; BMS-986016) in combination with nivolumab (nivo) in pts with melanoma (MEL) previously treated with anti-PD-1/PD-L1 therapy Meeting Abstract
| Authors: | Ascierto, P. A.; Melero, I.; Bhatia, S.; Bono, P.; Sanborn, R. E.; Lipson, E. J.; Callahan, M. K.; Gajewski, T.; Gomez-Roca, C. A.; Hodi, F. S.; Curigliano, G.; Nyakas, M.; Preusser, M.; Koguchi, Y.; Maurer, M.; Clynes, R.; Mitra, P.; Suryawanshi, S.; Munoz-Couselo, E. |
| Abstract Title: | Initial efficacy of anti-lymphocyte activation gene-3 (anti-LAG-3; BMS-986016) in combination with nivolumab (nivo) in pts with melanoma (MEL) previously treated with anti-PD-1/PD-L1 therapy |
| Meeting Title: | 53rd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 35 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2017 Jun 2-6 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2017-05-20 |
| Start Page: | 481s |
| Language: | English |
| ACCESSION: | WOS:000411932203163 |
| DOI: | 10.1200/JCO.2017.35.15_suppl.9520 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 9520 -- Source: Wos |
